About this trial
Chronic respiratory diseases like chronic obstructive pulmonary disease (COPD) are responsible for millions of deaths each year, the majority of which occur in low- and middle-income countries (LMICs). LMICs also have high rates of abnormal lung function, including restrictive spirometric pattern (RSP), which can precede the development of chronic respiratory diseases and is associated with all-cause mortality. Additionally, LMICs in sub-Saharan Africa are home to the majority of the world's population of people with HIV (PWH). HIV increases the risk of COPD and COPD associated mortality, but the mechanisms underlying this risk are incompletely understood.
Eligibility criteria
Qualifiers
Adults 35 years of age or older
In case at a clinic in Botswana
Documented HIV status
Ability to provide informed consent
Disqualifiers
Respiratory infection in the prior 4 weeks
Active pulmonary tuberculosis
Inability to perform spirometry including eye, abdominal, or
Thoracic surgery or myocardial infarction in the prior 6 weeks
Trial design
Treatments tested in this trial
- Not listed